直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 116924
著者
Miki, K Hayashi Hospital
板東, 浩 Hayashi Hospital|Tokushima University|Japan Low Carbohydrate Diet Promotion Association KAKEN研究者をさがす
Hayashi, K Hayashi Hospital
Dohi, A Japan Low Carbohydrate Diet Promotion Association
Kamoto, A Hayashi Hospital
キーワード
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs)
Oral semaglutide (Rybelsus)
Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC)
Fasting time period
資料タイプ
学術雑誌論文
抄録
Recent pharmacological topic for diabetes includes clinical application of Glucagon-like peptide 1 receptor agonists (GLP-1 RAs). Among them, oral semaglutide (Rybelsus) has been developed as the first oral form of GLP-1RA by useful application of sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC). Semaglutide concentration in the blood was compared when fasting time period after Rybelsus administration would be 15, 30, 60 and 120 minutes. As a result, the concentration ratio after 4 hours was 1.00, 1.67, 2.60 and 3.06, respectively. Authors have experienced a diabetic case of remarkable efficacy as HbA1c -1.4% and weight -5kg, who kept 3-4 hours fasting after Rybelsus intake.
掲載誌名
SunText Review of Medical & Clinical Research
ISSN
27664813
出版者
SunText Reviews
3
1
開始ページ
150
発行日
2022-04-04
権利情報
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系